CME/CE Accredited Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Strategies for Effective Pain Management in Clinical Practice
Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP
The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management in Clinical Practice curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including nonopioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse in order to optimally manage patients’ pain and medication use.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY
Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PAs
Supported by Opioid Analgesic REMS Program Companies
Evaluating the Use of Oral Corticosteroids in Asthma: Benefits and Risks
Andrea Fuller, FNP-BC, MSN, AE-C
Senior Respiratory Medical Science Liaison - AstraZeneca
Andrea Fuller is a Family Nurse Practitioner and Senior Respiratory Medical Science Liaison with AstraZeneca. She started her medical career 17 years ago as a Registered Nurse working in various departments including the Intensive Care Unit, Emergency Room, and Gastroenterology. She then received a Master’s of Science in Nursing as a Family Nurse Practitioner from Rush University in 2010. As a Nurse Practitioner, she worked as both an inpatient and outpatient provider in the fields of Neurology and Family Practice in which she treated numerous patients diagnosed with Asthma and COPD. She has been in her current position with AstraZeneca for over 4 years and is a certified Asthma educator. Prior to her roles in medicine, Andrea spent 4 years active duty serving our country in the US Air Force. She lives just outside Chicago and serves on the board for the Illinois Society for Advanced Practice Nursing.
Sponsored by AstraZeneca
Recognizing Developmental Delay: Early Identification of Pediatric Disorders in Primary Care, Including Rare Lysosomal Diseases
Barbara Burton, MD
This educational program will provide a practical overview pertaining to the significant role of primary care providers in pediatric developmental surveillance and screening. The importance of early developmental delay identification, with attention to neuromotor milestones, will be reviewed, including implications for rarer pediatric diseases, such as lysosomal storage disorders.
Northwestern University Feinberg School of Medicine, Attending Physician and Clinical Practice Director, Division of Genetics, Metabolism, and Birth Defects, Ann and Robert H. Lurie Children’s Hospital, Chicago, Illinois
Sponsored by Takeda Pharmaceuticals U.S.A., Inc.
A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies
Silvio E. Inzucchi, MD | Anne Peters, MD
This educational activity will review strategies to improve glycemic and extra-glycemic outcomes in patients with type 2 diabetes and explore the role of agents that target GIP and GLP-1 in the management of type 2 diabetes and obesity.
Professor of Medicine, Clinical Chief, Endocrinology, Medical Director, Yale Diabetes Center, Yale School of Medicine, Yale-New Haven Hospital, New Haven, CT
Professor of Clinical Medicine, Keck School of Medicine of USC, Los Angeles, CA
Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Ty J. Gluckman, MD, FACC, FAHA
Refresh your skills in managing common cardiovascular conditions in your primary care patient population during this session. Cardiology specialist Ty Gluckman, MD, will review important updates and considerations for managing your patients with hypertension, hypercholesterolemia and heart failure.
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR
A Proactive Way to Treat IBS-D: Post-Marketing Information and Phase 4 Data
Darren M. Brenner, MD
Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people.
Northwestern University, Feinberg School of, Medicine, Chicago, IL
Sponsored by AbbVie
Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
Jeff Unger, MD, FAAFP, FACE
Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.
Diplomate, American Board of Family Practice, Assistant Clinical Professor of Family Medicine, UC Riverside School of Medicine, Riverside, California, Director, Unger Concierge Primary Care Medical Group, Rancho Cucamonga, California
Sponsored by Novo Nordisk Inc.
Christopher S. Ogilvy, MD
One in fifty people in the U.S. has an unruptured brain aneurysm, and one ruptures every 18 minutes. Despite low frequency, brain aneurysms are high in mortality, because the lack of a timely diagnosis often leads to death. Complicating matters more, many of the symptoms are associated with other less dangerous conditions, such as influenza or stress. This session will describe the importance of early detection, since brain aneurysms are treatable via proper identification, and will highlight risk factors and populations who are most vulnerable. Faculty will also review treatment options for clinicians to recognize or use in practice.
Director, Endovascular and Operative Neurovascular Surgery, BIDMC Brain Aneurysm Institute, Professor of Neurosurgery, Harvard Medical School, Boston, MA
Supported by Brain Aneurysm Foundation Incorporated
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Brett Smith, DO
Sponsored by AbbVie
Sammy Saab, MD, MPH, AGAF | Yvonne I. Chu, MD, MBA
What do primary care providers need to know about HCV and glaucoma? Join expert faculty as they review important questions they get asked about these topics!
Professor, Medicine and Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, Head, Outcomes Research in Hepatology, David Geffen School of Medicine at UCLA, Los Angeles, CA
Professor, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX
Juliana (Jewel) Kling, MD, MPH, NCMP, FACP
Over the last year, important papers have been published that impact women’s health. In this 60-minute presentation, these important articles will be reviewed and cover topics from CVD risk and associated factors during the menopause transition, risk of breast cancer and menopausal hormone therapy, risk reducing medications for women at an elevated risk of breast cancer, the role of testosterone in postmenopausal women.
Associate Professor of Medicine, Chair, Women’s Health Internal Medicine, Associate Chair of Equity, Inclusion and Diversity, Department of Medicine, Mayo Clinic, Scottsdale, AZ
A Clinician’s Perspective on Managing Patients with Asthma
Monica Kraft, MD
Asthma is a significant public health concern in the US, making its diagnosis and management in clinical practice critically important, especially with recent increasing trends in prevalence and morbidity. With the help of engaging case-studies, this session will include discussions on the identification, diagnostic workup, and effective management of asthma. It will also review the assessment of symptom control and severity in patients with asthma.
Robert and Irene Flinn Professor of Medicine, Chair, Department of Medicine, College of Medicine, Tucson, Deputy Director, Asthma and Airway Disease Center, University of Arizona Health Sciences Center
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Case Study: A 51-Year-Old Female With Crohn’s Disease and Intestinal Resection*
Sukanya Subramanian, MD
*This is a hypothetical case and not an actual patient
Uncover the cause of the patient's symptoms in this virtual case study and consider if this could apply to any patients you manage.
Assistant Professor of Medicine, Medical Director of Adult Intestinal Rehabilitation and Transplantation, Medstar Georgetown University Hospital
Sponsored by Takeda Pharmaceuticals U.S.A., Inc.
Progression of CKD—Opportunities for Prevention Intervention and Mitigation
Surendra Sivarajah, MD
Field Physician, Biopharmaceuticals, US Medical | CVMD
Sponsored by AstraZeneca
Kalpana Gupta, MD, MPH | Jacob H. Johnson, MD
This pandemic required communication among specialists and primary care. In this COVID-19 panel, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.
Professor of Medicine, Boston University, School of Medicine, Boston, MA
Associate Physician, Division of Infectious, Diseases, Brigham and Women's Hospital, Boston, MA
Managing Myths and Misconceptions about Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation
Philip Schoenfeld, MD, MSEd, MSc
This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc..
Hidden in Plain Sight: Recognizing Manageable Conditions
Emily Glogowski, MS | Jennifer Clark Matthews, MS
This presentation will provide an introduction to lysosomal storage disorders (LSDs), a family of genetic diseases characterized by pathologic build-up of undegraded storage material in lysosomes as a result of enzyme deficiencies.
More than 50 LSDs have been identified, and many are now treatable. Five of these disorders will be discussed, providing an overview of the pathophysiology, and signs and symptoms of the diseases.
Methods of diagnosis will be described, including the availability of newborn screening for certain LSDs.
Medical Science Liaison
Medical Science Liaison
Sponsored by Sanofi Genzyme
AbbVie Treatment Innovations for Migraine Patients
Andrew Blumenfeld, MD
Presentation focus on AbbVie’s CGRP receptor antagonists for acute and preventive approaches for the treatment of migraines.
Director, The Headache Center of Southern California; The San Diego Headache Center and The Los Angeles Headache Center
Sponsored by AbbVie
Stephen N. Henry, DO, MS
Hip, knee, and back pain are common complaints in the outpatient setting. It is critical for primary care providers to develop an evidence-based systematic approach to address these complaints. This presentation will improve familiarity with anatomy of the hip, knee, and back through a case-based approach. Learners will be able to generate differential diagnoses for pain in the aforementioned regions and determine appropriate imaging studies using ACR Appropriateness Criteria. The learner will be able to identify cases that require subspecialty care.
Assistant Professor, Department of Orthopaedics, Department of Family Medicine and Community Health, Team Physician, University of Miami Intercollegiate Athletics, Team Physician, Miami Marlins, University of Miami Sports Medicine Institute, University of Miami Miller School of Medicine, Miami, Florida
Charles Vega, MD, FAAFP
In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses.
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA
Clinical Considerations in Coronary Artery Disease
Ted Okerson, MD, FACP, FACE
Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.
Sponsored by AstraZeneca Pharmaceuticals, LP